for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Novartis Cosentyx Receives FDA Approval For New Indication To Treat Active Non-Radiographic Axial Spondyloarthritis

June 16 (Reuters) - Novartis AG:

* NOVARTIS COSENTYX® RECEIVES FDA APPROVAL FOR NEW INDICATION TO TREAT ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS

* APPROVAL OF COSENTYX FOR NR-AXSPA IS BASED ON EFFICACY AND SAFETY OUTCOMES FROM PREVENT PHASE III STUDY Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up